1. Reithinger R, JC Dujardin, H Louzir, et al. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581-596.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305-18.
3. Serafim TD, Coutinho-Abreu IV, Dey R, et al. Leishmaniasis: the act of transmission. Trends Parasitol. 2021;37(11):976-987.
4. Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis. 2007;5(3):150-158.
5. Barati M, Sharifi I, Sharififar F, et al. Anti-leishmanial activity of Gossypium hirsutum L., Ferula assa-foetida L. and Artemisia aucheri Boiss extracts by colorimetric assay. Anti-Infect Agents. 2014;12(2):159-164.
6. Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop. 2011;118(2):87-96.
7. Bailey F, Mondragon-Shem K, Hotez P, et al. A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis. 2017;11(8):0005739.
8. Karami M, Gorgani-Firouzjaee T, Chehrazi M. Prevalence of cutaneous Leishmaniasis in the Middle East: a systematic review and meta-analysis. Pathog Glob Health. 2023;117(4):356-365.
9. Hailu A. The use of direct agglutination test (DAT) in serological diagnosis of Ethiopian cutaneous leishmaniasis. Diagn Microbiol Infect Dis. 2002;42(4):251-256.
10. Rasti S, Ghorbanzadeh B, Kheirandish F, et al. Comparison of molecular, microscopic, and culture methods for diagnosis of cutaneous leishmaniasis. J Clin Lab Anal. 2016;30(5):610-615.
11. Vega-López F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis. 2003;16(2):97-101.
12. Faber WR, Oskam L, van Gool T, et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol. 2003;49(1):70-74.
13. Aronson NE, Joya CA. Cutaneous leishmaniasis: updates in diagnosis and management. Infect Dis. Clin North Am. 2019;33(1):101-117.
14. Pourmohammadi B. Motazedian MH, Hatam GR, et al. Comparison of three methods for diagnosis of cutaneous leishmaniasis. Iranian J Parasitol. 2010;5(4):1-8.
15. Singh S. New developments in diagnosis of leishmaniasis. Indian J Med Res. 2006;123(3):311-30.
16. Carstens-Kass J, Paulini K, Lypaczewski P, et al. A review of the Leishmanin skin test: A neglected test for a neglected disease. PLoS Negl Trop Dis. 2021;15(7):e0009531.
17. Manzur A. Sensitivity of Leishmanin skin test in patients of acute cutaneous leishmaniasis. Dermatol Online J. 2006;12(4): 2.
18. Hashemi SN, Mohebali M, Mansouri P, et al. Comparison of Leishmanin skin test and direct smear for the diagnosis of cutaneous leishmaniasis. Acta Med Iran. 2011; 49(3):136-41.
19. Alimohammadian M, Hakimi H, Nikseresht M. The preparation and evaluation of reference Leishmanin from Leishmania major for use in man for diagnostic and experimental purposes. Med J Islam Repub Iran. 1993;7:23–8.
20. Mohebali M, Edrisian G. H, Nadim A, et al. Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in Iran. Iran J Parasitol. 2006;1:15-25.
21. Mohebali M, Keshavarz H, Shirmoham-mad S, et al. The diagnostic accuracy of direct agglutination test for serodiagnosis of human visceral leishmaniasis: a systematic review with meta-analysis. BMC Infect Dis. 2020;20:946.
22. Molaie S, Mohebali M, Abaiet MR, et al. Alteration of Direct Agglutination Test (DAT) results in Iranian Kala-Azar patients: a case series. J Parasit Dis. 2017;41:446-449.
23. Mengistu G, Kiessling R, Akuffo H. The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg. 1990;84(3):359-362.
24. Sabzevari, S, Teshnizi SH, Shokri A, et al. Cutaneous leishmaniasis in Iran: a systematic review and meta-analysis. Microb Pathog. 2021;152:104721.
25. Feiz-Haddad MH, Kassiri H, Kasiri N. Prevalence and epidemiologic profile of acute cutaneous leishmaniasis in an endemic focus, Southwestern Iran. J Acute Dis. 2015;4:292-297.
26. Sharifi I, Khosravi A, Aflatoonian MR, et al. Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan. Front Public Health. 2023; 11:1091709.
27. Miramin-Mohammadi A, Javadi A, Eskandari SE, et al. Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions. Iran J Microbiol. 2020;12(3):249-255.
28. Alimohammadian MH, Jones SL, Darabi H, et al. Assessment of interferon-γ levels and Leishmanin skin test results in persons recovered for leishmaniasis. Am J Trop Med Hyg. 2012;87(1):70-5.
29. Sadeghian G, Ziaei H, Bidabadi LS, et al. Evaluation of Leishmanin skin test reaction in different variants of cutaneous leishmaniasis. Indian J Dermatol. 2013;58(3):239.
30. Norouzinezhad F, Ghaffari F, Norouzinejad A, et al. Cutaneous lei-shmaniasis in Iran: results from an epidemiological study in urban and rural provinces. Asian Pac J Trop Biomed. 2016;6(7):614-619.
31. Pouresmaeiliyan S, Sharifi I, Aflatoniyan MR, et al. A new focus of anthroponotic cutaneous leishmaniasis in Dehbakry region of Bam district, southeastern Iran 2008. J Kerman Univ Med Sci.. 2010;16(1):15-24.
32. Mehregan DR, Mehregan AH, Mehregan DA, et al. Histologic diagnosis of cutaneous leishmaniasis. Clin Dermatol. 1999;17(3):297-304.
33. Ramírez JR, Agudelo S, Muskus C, et al. Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis. J Clin Microbiol. 2000;38(10):3768-3773.
34. Saab MEl, Hage H, Charafeddine K, et al. Diagnosis of cutaneous leishmaniasis: why punch when you can scrape? Am J Trop Med Hyg. 2015;92(3):518-22.
35. Weigle KA, de Davalos M, Heredia, et al. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg. 1987;36(3):489-496.
36. Navin TR., Arana FE, de Mérid AM, et al. Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods. Am J Trop Med Hyg.1990;42(1)36-42.
37. Pena HP, Belo VS, Xavier-Junior JCC, et al. Accuracy of diagnostic tests for American tegumentary leishmaniasis: a systematic literature review with meta-analyses. Trop Med Int Health. 2020;25(10):1168-1181.
38. Azmi K, Nasereddin A, Ereqat S, et al. Methods incorporating a polymerase chain reaction and restriction fragment length polymorphism and their use as a ‘gold standard’in diagnosing Old World cutaneous leishmaniasis. Diagn Microbiol Infect Dis. 2011;71(2):151-155.
39. de Vries HJ, Reedijk SH, Schallig HD, et al. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16:99-109.
40. Montenegro J. Cutaneous reaction in leishmaniasis. Arch Dermatol Syph, 1926;13(2):187-194.
41. Pampiglione S, Manson-Bahr PEC, La Placa M, et al. Studies on Mediterranean leishmaniasis IV. The Leishmanin skin test in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1976;70(1):62-65.
42. Manson-Bahr P. Clinical aspects and control: Diagnosis in: The leishmaniases in biology and medicine. 1987;Academic Press, London & New York.
43. Dostrovsky A, Sagher F. The intracutaneous test in cutaneous leishmaniasis. Ann Trop Med Parasitol. 1946;40(3-4):265-269.
44. Sadeghian G, Momeni A, Siadat AH, et al. Evaluation of Leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis. Dermatol Online J. 2006;12(7):3.
45. Alimohammadian MH, Fariba Kojori Z, Darabi H, et al. Soluble Leishmanin as an Ideal Reagent for Skin Testing in Human Leishmaniasis. Iran Biomed J. 1997;1(4):39-47.
46. Roberts T, Keddie SH, Rattanavong S, et al. Accuracy of the direct agglutination test for diagnosis of visceral leishmaniasis: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):782.
47. El Safi S, Evans DA. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Trans R Soc Trop Med Hyg. 1989;83(3):334-337.